GlassScriptPhysician profile
Stephanie L Lowry
NPI 1962600312
$1,219.66
in general payments reported to CMS, 2019-2025
19 companies · $67.59 in 2025
The $67.59 reported for 2025 was less than what a typical Adolescent Medicine (Family Medicine) provider received nationally (typical 2025 total: $135).
See the full distribution for Adolescent Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.23 · 2020: $88.33 · 2021: $402 · 2022: $450 · 2023: $53.52 · 2024: $103 · 2025: $67.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $539.65 | 2020-2022 | |
| Baxter Healthcare | $97.68 | 2022 | |
| Exeltis, USA INC. | $89.60 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $73.52 | 2022-2023 | |
| Astellas Pharma US INC | $52.87 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $50.32 | 2023-2024 | Aptima, Coolseal Generator, Novasure |
| Biohaven Pharmaceuticals, INC. | $45.40 | 2021 | |
| Mayne Pharma Commercial LLC | $44.28 | 2021-2022 | |
| Covidien LP | $44.19 | 2019 | |
| Scynexis, INC. | $30.30 | 2022 | |
| Minerva Surgical, INC | $28.46 | 2024 | |
| Medtronic, INC. | $26.97 | 2024 | Ligasure |
| Mylan Pharmaceuticals INC. | $18.42 | 2021 | |
| Pfizer INC. | $16.41 | 2023 | |
| Sumitomo Pharma America, INC. | $14.15 | 2025 | Myfembree |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $12.82 | 2022 | |
| Evofem Biosciences, INC. | $11.92 | 2021 | |
| Currax Pharmaceuticals LLC | $11.66 | 2022 | |
| Glaxosmithkline, LLC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Lowry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.